Neurosense Therapeutics Eulerpool Ziņas

Neurosense Therapeutics Eulerpool News

Neurosense Therapeutics Akciju Ziņas

Neurosense Therapeutics tiek uzmanīgi vēroti no žurnālistu un investoru puses visā pasaulē. Jaunākās Neurosense Therapeutics ziņas mēs apkopojam šeit.

• 16. augusts ·

  TipRanks
  NeuroSense Therapeutics Announces Share Issuance
• 7. augusts ·

  Yahoo
  NeuroSense Therapeutics Announces Private Placement with Senior Management Participation at Premium to Market Price
• 7. augusts ·

  TipRanks
  NeuroSense Therapeutics Announces Strategic Securities Sale
• 1. augusts ·

  Yahoo
  NeuroSense Therapeutics Announces Positive Biomarker Data from ALS Phase 2b Clinical Trial
• 1. augusts ·

  TipRanks
  NeuroSense’s ALS Drug Shows Promise in Trial
• 1. augusts ·

  Thefly.com
  NeuroSense's PrimeC shows positive biomarker data from ALS Phase 2b trial
• 9. jūlijs ·

  Yahoo
  NeuroSense's PARADIGM ALS Clinical Trial Demonstrates Up to 73% Improved Complication-Free Survival Following Statistically Significant Slowing of Disease Progression
• 1. jūlijs ·

  Yahoo
  NeuroSense Demonstrates Statistically Significant Efficacy and Survival Benefits in People Living with ALS: The Promising Results from the 12-Month PARADIGM Study Highlight PrimeC's Potential as a Disease Modifying Drug
• 27. jūnijs ·

  TipRanks
  NeuroSense Extends Warrant Termination, Revises Terms
• 24. jūnijs ·

  Yahoo
  NeuroSense Management Provides Corporate Update and First Quarter 2024 Financial Results